BoardNext is an initiative of the Women Corporate Directors (WCD) Foundation designed for experienced, highly qualified, board-ready women which offers educational programming, exceptional resources and peer group support to navigate the path to their first public corporate board. WCD is the largest global organization serving the needs of female directors. BoardNext members will gain access to select WCD resources, networking opportunities, and search firm executives.
Stay connected with the latest
No content found
Private Equity in the Board Room
Join us to learn how Private Equity firm TPG is influencing governance, improving board performance and making gender diversity a top priority.
Felicia Gorcyca is a Director at TPG Capital based in San Francisco and a member of the Global Human Capital team and Operations Group, where she focuses on building leadership teams and Boards for TPG Capital portfolio companies.
Prior to joining TPG, Felicia served as Chief People Officer for Blue Star Sports and Global Head of People Operations for Solera Holdings, Inc. Previously, Felicia spent thirteen years with Spencer Stuart, most recently as a Consultant in the Healthcare Services and Executive
Felicia holds a degree in International Business from Pepperdine University and a Master in Public Health from UCLA.
Natasha Deckmann, M.D.
Natasha Deckmann, M.D. serves as an Independent Board Director for both AARP Service Inc.
and Women's Health USA.
She recently concluded her role as the Chief Executive Officer for CarePoint Health, leading the health care system that includes three New Jersey hospitals – Bayonne Medical Center, Christ Hospital in Jersey City, and Hoboken University Medical Center as well as two affiliated Physician Groups.
As CEO, Natasha was responsible for the
direction of the largest private employer in Hudson County, with nearly 4,500 employees who deliver the highest level of healthcare to the area’s urban population.
Lindsay M. LaCava
Lindsay M. LaCava is a partner of the Firm’s Tax Practice Group in New York and advises individual and business clients on a full range of state and local tax issues.
She was named a “Rising Star” in Tax Law in 2015 by Law360, and was selected by Super Lawyers as a New York-Metro "Rising Star" for Tax in 2013-2015.
Prior to joining Baker McKenzie, Ms. LaCava was a partner in the state and local tax group of an international law firm. In addition, she previously worked at a Big Four accounting firm, where her practice focused exclusively on state and local tax.
Ms. LaCava speaks on a variety of state tax topics at events around the country and also frequently writes about state and local tax issues.
452 Fifth Avenue
New York, NY 10018
**Check in with the security desk. Photo ID will be required
This event is free for BoardNext and WCD members who are current with their membership dues and $175 for non-members.
4th Annual Signature Event
How I Secured My First Board
While there is not a single path to board service, there are several steps you can take to become more successful in your pursuit of your first board.
Be present at our 4th annual signature event and network with WCD members as they share their journey onto recent board assignments. The panel will highlight what worked for them individually and what are the critical activities you should be engaging in as you position yourself for your first board.
Pam has 18 years of experience as a public company director, serving on six public company boards where she has been chair of the board, presiding director, and chaired audit and compensation committees. Pam is co-chair of the Boston chapter of WCD and a member of the Boston Women Leaders Network, Massachusetts Women's Forum and the Boston Club.
David serves as Chair of the Governance and Risk Assessment Committee and a member of the Audit Committee of International Seaways (NYSE: INSW). David's previous board experience includes serving as an independent director - and a member of both the Audit and Compensation Committees - of APCO Worldwide, and as a director of Clean Tech Group.
Dr. Rivas is a first time board director. She was appointed by Medidata Solutions to serve on their board and is a member of the Audit and Compensation Committees. She currently serves as Chief Medical Officer at the biopharma business of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the U.S. and Canada.
Maria P. Eberle is a member of the Firm's Tax Group in New York and she also serves as chair of the SALT subpractice group. She advises multinational companies on a full range of state and local tax matters, including tax controversy and litigation.